newsfilter
← Latest News
GlobeNewswire·

Nkarta to Participate in November Investor Conferences

  • Nkarta, Inc. (NASDAQ: NKTX) announced participation in two upcoming investor conferences.
  • The company will present at the Stifel 2025 Healthcare Conference on November 12, 2025, at 10:40 a.m. ET.
  • Nkarta will also speak at TD Cowen's Immunology & Inflammation Summit on November 13, 2025, at 5 p.m. ET.
  • A simultaneous webcast of both fireside chats will be available on the Investors section of Nkarta's website, www.nkartatx.com.
  • Event replays will be archived on the company website for approximately 90 days.
  • Nkarta is a clinical-stage biotechnology company developing allogeneic, off-the-shelf natural killer cell therapies for autoimmune diseases.
  • The company utilizes cell expansion, cryopreservation, & CRISPR-based genome engineering to build its pipeline of engineered cell therapies.
  • Nadir Mahmood is listed as the Nkarta Media/Investor Contact.